**Adverse Reactions: Severe**

- Hives and rash

- Stevens-Johnson syndrome

**Adverse Reactions: Mild**

- Sleepiness

- Diarrhea

- Weakness

- Tiredness

- Constipation

- Gas

- Stomach pain

- Heartburn

- Nausea

- Hiccups

- Loss of appetite

- Headache

- Fever

- Itching

- Hair loss

**Pregnancy**

Do not take neurokinin-1 (NK-1) receptor antagonists if pregnant or planning to get pregnant or breastfeeding. During treatment with neurokinin-1 (NK-1) receptor antagonists, if a patient is on birth control medication, the patient should use an additional method of birth control to avoid unplanned or unwanted pregnancy. Additionally, the patient should continue with other pregnancy protection for one month after treatment with neurokinin-1 (NK-1) receptor antagonists, e.g., aprepitant. It was FDA classified as pregnancy Class B under the prior system for pregnancy classification.

**Drug Interactions**

Potential drug interactions can occur with neurokinin-1 (NK-1) receptor antagonists with concomitant medications because of changes in drug metabolism, e.g., CYP3A4 inhibition; this can occur in patients taking prescription and non-prescription medications, as well as herbal and nutritional supplements. The following is a list of potential drug interactions that may require drug monitoring or avoid combination: warfarin (monitor therapy); ivabradine (avoid combination); antifungals such as ketoconazole and itraconazole; lansoprazole; clarithromycin; diltiazem; carbamazepine; HIV protease inhibitors, such as ritonavir, and nelfinavir; hormonal contraceptives; nefazodone; oral steroids such as dexamethasone and methylprednisolone; paroxetine; phenytoin; cancer chemotherapy medications such as docetaxel, etoposide, ifosfamide, imatinib, irinotecan, paclitaxel, tamoxifen, vinblastine, vincristine, and vinorelbine; rifampin; tolbutamide; and troleandomycin; benzodiazepines such as alprazolam, diazepam, midazolam, and triazolam.